Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT Elderly: Myocet and Cyclophosphamide in Elderly Breast Cancer
NCT02214381Phase 3Completed
- Sponsor
- Westdeutsche Studiengruppe
- Start
- Jul 2014
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in breast cancer, sponsored by Westdeutsche Studiengruppe. Started Jul 2014; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02214381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214381.